×
About 2,080 results

ALLMedicine™ Onychomycosis Center

Research & Reviews  543 results

JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
https://www.ncbi.nlm.nih.gov/pubmed/34303391
Skinmed Gupta AK, Venkataraman M et. al.

Jul 26th, 2021 - Onychomycosis is a chronic fungal infection of the nails and is commonly observed in adults, especially the elderly, those who are diabetic, have poor peripheral circulation, and are immunocompromised; however, onychomycosis in children is being r...

Characterization of a biofilm formed by Fusarium oxysporum on the human nails.
https://doi.org/10.1111/ijd.15747
International Journal of Dermatology; Veiga FF, de Castro-Hoshino LV et. al.

Jul 9th, 2021 - Fusarium spp. has been considered as an onychomycosis agent, but little is known about the etiopathogenesis of fusarial onychomycosis; thus, the objective of this study was to characterize the fungal-nail interaction and the consequences of the na...

Efficacy of lasers for the management of dermatophyte toenail onychomycosis.
https://doi.org/10.7547/20-236
Journal of the American Podiatric Medical Association; Gupta AK, Venkataraman M et. al.

Jul 8th, 2021 - Onychomycosis is a chronic fungal nail infection caused predominantly by dermatophytes, and less commonly by non-dermatophyte molds (NDMs) and Candida species. Onychomycosis treatment includes oral and topical antifungals, the efficacy of which is...

One size does not fit all: the need for individualized treatment based on factors that ...
https://doi.org/10.1111/ijd.15739
International Journal of Dermatology; Gupta AK, Venkataraman M et. al.

Jul 4th, 2021 - Successful management of onychomycosis is a challenge because cure rates with most antifungals are relatively low and recurrence rates are high. A drug-based approach by treating the nail alone may not suffice. There are several host-related facto...

Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis wit...
https://doi.org/10.1111/1346-8138.16035
The Journal of Dermatology; Watanabe S, Iozumi K et. al.

Jul 3rd, 2021 - Onychomycosis with longitudinal spikes in the nail plate has been reported to be refractory to oral drugs as with dermatophytoma. We evaluated the efficacy of 10% efinaconazole solution in the treatment of onychomycosis with longitudinal spikes. O...

see more →

Guidelines  1 results

Treatment of nail psoriasis: best practice recommendations from the Medical Board of th...
https://doi.org/10.1001/jamadermatol.2014.2983
JAMA Dermatology; Crowley JJ, Weinberg JM et. al.

Dec 5th, 2014 - Nail psoriasis can be difficult to treat and has a significant effect on quality of life. Relatively few controlled trials evaluating treatments for nail psoriasis have been published. There is an unmet need for treatment recommendations to guide ...

see more →

Drugs  115 results see all →

Clinicaltrials.gov  57 results

Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
https://clinicaltrials.gov/ct2/show/NCT03216200

Oct 11th, 2019 - The purpose of this study is to assess the clinical feasibility of DeviceFarm, Inc.'s RenewalNail™ system and the treatment protocol that was developed based on extensive laboratory testing on human cadaver nails. The Protocol calls for three 45-m...

Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail Onychomycosis
https://clinicaltrials.gov/ct2/show/NCT03280927

May 8th, 2019 - Evaluate anti-fungal activity and safety of efinaconazole in patients with mild to moderate toenail onychomycosis caused by dermatophytes that received a 48-week administration of efinaconazole.

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
https://clinicaltrials.gov/ct2/show/NCT01302119

Apr 3rd, 2019 - The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
https://clinicaltrials.gov/ct2/show/NCT01270971

Feb 22nd, 2019 - The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail
https://clinicaltrials.gov/ct2/show/NCT01278394

Dec 6th, 2018 - In this cohort, only the targeted great toenail identified at Baseline prior to the commencement of treatment from culture results collected at the Screening visit were evaluated for primary efficacy whereas all treated toenails were evaluated for...

see more →

News  116 results

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.medscape.com/viewarticle/935774

Aug 17th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

Three in Four Adults 70 and Older Have at Least One Skin Disease
https://www.staging.medscape.com/viewarticle/935774

Aug 17th, 2020 - (Reuters Health) - Skin diseases are highly prevalent among adults aged 70 years and older, with 75.7% of people in this age range reporting at least one skin disease requiring treatment or follow-up, a study in Finland suggests. Researchers exami...

FDA Drug Approvals, Dermatology — 2020 Midyear Review
https://reference.medscape.com/viewarticle/935244

Aug 14th, 2020 - Dupixent (dupilumab) - Indicated for moderate-to-severe atopic dermatitis not adequately controlled with topical prescription therapies or when those therapies are not advisable in children aged 6 years or older. Jublia (efinaconazole) - Indicatio...

Study Compares Pulse vs Continuous Therapy for Dermatophyte Toenail Onychomycosis
https://www.staging.medscape.com/viewarticle/932903

Jun 24th, 2020 - There appear to be no differences in efficacy or safety between pulse and continuous regimens of terbinafine and no differences between pulse and continuous regimens of itraconazole for dermatophyte toenail onychomycosis, results from a systematic...

Nail growth
https://www.mdedge.com/familymedicine/article/218427/oncology/nail-growth?channel=203
MDedge Family Medicine;

Mar 5th, 2020 - The treatment failure with the terbinafine made onychomycosis unlikely, and the appearance of the finger did not suggest that this was a wart. So, the physician opted for a 4-mm punch biopsy of the lateral nail fold, which confirmed that this was.

see more →